{
  "id": 20290580,
  "title": "Lilly's 14th acquisition of the year is a little-known blood cancer biotech",
  "url": "https://urgent.news/2026/11/16/lillys-14th-acquisition-of-the-year-is-a-little-known-blood-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T14:37:18.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lillys-14th-acquisition-of-the-year-is-a-little-known-blood-cancer-biotech/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly has been on a shopping spree this year thanks to its GLP-1-driven revenue, and its 14th acquisition of 2026 is in cancer, the domain of expertise for the pharma's head ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}